Sage Journals: Discover world-class research

Abstract

Syphilis, a slow progressive and the third most common sexually transmitted disease found worldwide, is caused by a spirochete gram negative bacteria Treponema pallidum. Emergence of antibiotic resistant T. pallidum has led to a search for novel drugs and their targets. Subtractive genomics analyses of pathogen T. pallidum and host Homo sapiens resulted in identification of 126 proteins essential for survival and viability of the pathogen. Metabolic pathway analyses of these essential proteins led to discovery of nineteen proteins distributed among six metabolic pathways unique to T. pallidum. One hundred plant-derived terpenoids, as potential therapeutic molecules against T. pallidum, were screened for their drug likeness and ADMET (absorption, distribution, metabolism, and toxicity) properties. Subsequently the resulting nine terpenoids were docked with five unique T. pallidum targets through molecular modeling approaches. Out of five targets analyzed, D-alanine:D-alanine ligase was found to be the most promising target, while terpenoid salvicine was the most potent inhibitor. A comparison of the inhibitory potential of the best docked readily available natural compound, namely pomiferin (flavonoid) with that of the best docked terpenoid salvicine, revealed that salvicine was a more potent inhibitor than that of pomiferin. To the best of our knowledge, this is the first report of a terpenoid as a potential therapeutic molecule against T. pallidum with D-alanine:D-alanine ligase as a novel target. Further studies are warranted to evaluate and explore the potential clinical ramifications of these findings in relation to syphilis that has public health importance worldwide.

Get full access to this article

View all access options for this article.

References

Anishetty

, Pulimi

, and Pennathur

. (2005). Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Comp Biol Chem, 29, 368–378.

Balani

, Mewa

, Gan

, Wu

, and Lee

. (2005). Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection. Curr Top Med Chem, 5, 1033–1038.

Barh

, and Kumar

. (2009). In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae. In Silico Biol, 9, 225–231.

Barh

, Kumar

, and Misra

. (2009). Genomic Target Database (GTD): A database of potential targets in human pathogenic bacteria, Bioinformation, 4, 50–51.

Barh

, Tiwari

, Jain

, et al. (2011). In Silico subtractive genomics for target identification in human bacterial pathogens. Drug Dev Res, 72, 162–177.

Borrock

, Kiessling

, and Forest

. (2007). Conformational changes of glucose/galactose-binding protein illuminated by open, unliganded, and ultra-high-resolution ligand-bound structures. Protein Sci, 16, 1032–1041.

Bruning

, Murillo

, Chacon

, Barletta

, and Sacchettini

. (2010). Structure of the Mycobacterium tuberculosis D-Alanine:D-Alanine ligase, a target of the antituberculosis drug D-Cycloserine. Antimicrob Agents Chemother, 55, 291–301.

Cai

, Han

, Ji

, Chen

, and Chen

. (2003). SVM-Prot: Web-based support vector machine software for functional classification of a protein from its primary sequence. Nucleic Acids Res, 31, 3692–3697.

Djorjevic

, and Stock

. (1997). Crystal structure of the chemotaxis receptor methyltransferase CheR suggests a conserved structural motif for binding S-adenosylmethionine. Structure, 5, 545–558.

10.

Echenburg

, and Scronbrunn

. (2000). Comparative X-ray analyses of un-liganded fosfomycin-target MurA. Proteins: Struct Funct Genet, 40, 290–298.

11.

Fraser

, Norris

, Wienstock

, et al. (1998). Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science, 281, 375.

12.

Egan

, Merz

Jr , and Baldwin

. (2000). Prediction of drug absorption using multivariate statistics. J Med Chem, 43, 3867–3877.

13.

Gardy

, Laird

, Chen

, et al. (2005). PSORTb v.2.0: Expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics, 21, 617–623.

14.

, Florjancic

, Clark

, et al. (2004). Structure-activity relationships of novel potent MurF inhibitors. Bio Med Chem Lett, 14, 267–270.

15.

Hook

III , and Peeling

. (2004). Syphilis control: A continuing challenge. N Engl J Med, 351, 122–124.

16.

Ismail

, Arif

, Deena-Al

, et al. (2012). Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11. Interdiscip Sci Comput Life Sci, 6, 48–56.

17.

Jang

, Jonghe

, Segers

, Anne

, and Herdwijin

. (2010). Synthesis of novel 5-amino-thiazolo(4,5-d)pyrimidines as E. coli and S. Aureus SecA inhibitors. Bioorg Med Chem, 19, 702–714.

18.

Katz

, and Klausner

. (2008). Azithromycin resistance in Treponema pallidum. Curr Opin Infec Dis, 21, 83–91.

19.

Kushwaha

, and Shakya

. (2010). Protein interaction network analysis—Approach for potential drug target identification in Mycobacterium tuberculosis. J Theor Biol, 262, 284–294.

20.

Laskowski

, MacArthur

, Moss

, and Thornton

. (1993). PROCHECK: A program to check the steriochemical quality of protein structure. J App Cryst, 26, 283–291.

21.

, Huang

, Tai

, and Wang

. (2008). Discovery of the first SecA inhibitors using structure-based virtual screening. Biochem Biophy Res Comm, 368, 839–845.

22.

Liu

, Chang

, Herberg

, et al. (2006). Allosteric inhibition of Staphylococcus aureus D-alanine:D-alanine ligase revealed by crystallographic studies. Proc Natl Acad Sci USA, 103, 15178–15183.

23.

Lovering

, Safadi

, and Strynadka

NCJ

. (2012). Structural perspective of peptidoglycan biosynthesis and assembly. Annu Rev Biochem, 81, 451–478.

24.

Marra

, Colina

, Godornes

, et al. (2006). Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum. J Infect Dis, 194, 771–1773.

25.

Matejkova

, Strouhal

, Smajs

, et al. (2008). Complete genome sequence of Treponema pallidum ssp. Pallidum strain SS14 determined with oligonucleotide arrays. BMC Microbiol, 8, 16.

26.

McGuffin

, Bryson

, and Jones

. (1999). The PSIPRED protein structure prediction server. Bioinformat App Note, 16, 404–405.

27.

Michael

, and Eugene

. (1999). Searching for drug targets in microbial genomes. Curr Opin Biotech, 10, 571–578.

28.

Mitchell

, Engelman

, Kent

, Lukehart

, Godornes

, and Klausner

. (2006). Azithromycin-resistant syphilis infection: San Francisco, California, 2000–2004. Clin Infec Dis, 42, 337–345.

29.

Moriya

, Itoh

, Okuda

, Yoshizawa

, and Kanehisa

. (2007). KAAS: An automatic genome annotation and pathway reconstruction server. Nucleic Acids Res, 35, 182–185.

30.

Morris

, Goodsell

, Halliday

, et al. (1999). Automated docking using a Lamarkian genetic algorithm and an empirical binding free energy function. J Comput Chem, 19, 1639–1662.

31.

Morris

, Huey

, Lindstrom

, et al. (2009). AutoDock4 and AutoDock tools4: Automated docking with selective receptor flexibility. J Comput Chem, 30, 2785–2791.

32.

Norris

and The Treponema pallidum Polypeptide Research Group. (1993). Polypeptides of Treponema pallidum: Progress towards understanding their structural, functional and immunologic roles. Microbiol Rev, 57, 750–779.

33.

Norris

, Charon

, Cook

, Fuentes

and Limberger

. (1988). Antigenic relatedness and N-terminal homology define two classes of periplasmic flagellar proteins of Treponema pallidum subsp. pallidum and Treponema phagedenis. J Bacteriol, 170, 4072–4082.

34.

Osborne

, Clemons

Jr , and Rapoport

. (2004). A large conformational change of translocation ATPase SecA. Proc Natl Acad Sci USA, 101, 10937–10942.

35.

Pettersen

, Goddard

, Huang

, et al. (2004). UCSF Chimera—A visualization system for exploratory research and analysis. J Comput Chem, 25, 1605–1612.

36.

Segall

, Beresford

, Gola

, Hawksley

, and Tarbit

. (2006). Focus on success: Using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery. Expert Opin Drug Metab Toxicol, 2, 325–337.

37.

Sharma

, Gupta

, and Dixit

. (2006). In silico identification of putative drug targets from different metabolic pathways of Aeromonas hydrophila. In Silico Biol, 8, 331–338.

38.

Smith

, Kamp

, Olansky

, and Price

. (1956). Benzathine penicillin G in the treatment of syphilis. Bull World Health Organ, 15, 1087–1096.

39.

Stamm

. (2010). Global challenge of antibiotic resistant Treponema pallidum. Antimicrob Agents Chemother, 54, 583–589.

40.

Steven

. (2002). New (and not so new) antibacterial targets—From where and when will the novel drugs come. Curr Opin Pharmaco, 2, 513–522.

41.

Tatusov

, Fedorova

, Jackson

, et al. (2003). The COG database: An updated version includes eukaryotes. BMC Bioinformatics, 4, 41.

42.

Wallner

, and Elofsson

. (2003). Can correct protein models be identified?. Protein Sci, 12, 1073–1086.

43.

Walsh

. (1989). Enzymes in the D-alanine branch of bacterial cell wall peptidoglycan assembly. J Biol Chem, 264, 393–396.

44.

, Kong

, Han

, Chen

, Hu

, Jiang

, and Shen

. (2008). D-alanine:D-alanine ligase as a new target for flavanoids quercetin and apigenin. Int J Antimicrob Agents, 32, 421–426.

45.

, Mao

, Cai

, Luo

, and Wei

. (2006). KOBAS server: A web-based platform for automated annotation and pathway identification. Nucleic Acids Res, 34, W720–W724.

46.

Xie

, Mao

, Huang

, et al. (2011) KOBAS 2.0: A web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res, 39, 316–322.

47.

Zhang

, and Lin

. (2009). DEG 5.0 a database of essential genes in both prokaryotes and eukaryotes. Nucleic Acids Res, 37, 455–458.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.30 MB

0.02 MB

0.11 MB

0.22 MB

0.14 MB

0.19 MB

Treponema pallidum Putative Novel Drug Target Identification and Validation: Rethinking Syphilis Therapeutics with Plant-Derived Terpenoids

Abstract

Abstract

Get full access to this article

References

Supplementary Material